N-methyl-D-aspartate receptor polyamine binding site (NMDAR polyamine site)

The spermine binding site is a distinct allosteric modulatory site located on the N-methyl-D-aspartate (NMDA) receptor complex, primarily involving the GluN1 and GluN2B subunits (NIH, 1991; NIH, 2007). Endogenous polyamines like spermine and spermidine act as agonists at this site, exerting complex triphasic effects: they potentiate receptor activity by increasing the affinity for the co-agonist glycine and increasing channel opening frequency (glycine-independent stimulation), but they also cause voltage-dependent inhibition at higher concentrations by blocking the ion channel pore (NIH, 2007; MDPI, 2020). This site is a significant therapeutic target because its modulation can fine-tune NMDA receptor function, which is critical for synaptic plasticity, learning, and memory (Wikipedia, 2024). Dysregulation of polyamine-mediated NMDA receptor activity is implicated in various neurological conditions, including stroke-induced excitotoxicity, epilepsy, and neurodegenerative diseases like Alzheimer's (NIH, 1991; ResearchGate, 2013). Pharmacological agents targeting this site, such as ifenprodil and its derivatives, aim to provide neuroprotection or treat psychiatric disorders by selectively modulating specific NMDA receptor subtypes while minimizing the severe side effects associated with non-selective channel blockers (NIH, 2007; ResearchGate, 2013). Beyond the NMDA receptor, spermine also interacts with other neuronal targets like AMPA receptors and inward-rectifier potassium channels, though the NMDA receptor site remains the primary focus of drug development (NIH, 2007).

Other names

Polyamine recognition siteSpermine modulatory siteNMDA receptor polyamine sitePolyamine binding site

Allosteric modulation of the NMDA receptor, including glycine-dependent and glycine-independent potentiation of current, and voltage-dependent channel blockade at high concentrations.